Covered recipient · General Payments record
IVELISSE IRIZARRY ARCE
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2021
$1,045.30
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $160.94 | 2 |
| Food and Beverage | $158.52 | 8 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $160.94 | 2 |
| Janssen Pharmaceuticals, Inc | $55.52 | 3 |
| GENZYME CORPORATION | $49.90 | 2 |
| PBG PUERTO RICO LLC | $20.20 | 1 |
| Clovis Oncology, Inc. | $16.95 | 1 |
| ABBVIE INC. | $15.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $15.95 | 03/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794918165 | CMS |
| Clovis Oncology, Inc. | $16.95 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 790254369 | CMS |
| GENZYME CORPORATION | $24.95 | 03/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 843773525 | CMS |
| GENZYME CORPORATION | $24.95 | 07/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 843773541 | CMS |
| Janssen Biotech, Inc. | $99.95 | 01/12/2021 | Education | Undisputed | 01/23/2026 | 788589877 | CMS |
| Janssen Biotech, Inc. | $60.99 | 10/05/2021 | Education | Undisputed | 01/23/2026 | 788589879 | CMS |
| Janssen Pharmaceuticals, Inc | $16.46 | 01/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788589871 | CMS |
| Janssen Pharmaceuticals, Inc | $19.81 | 03/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788589873 | CMS |
| Janssen Pharmaceuticals, Inc | $19.25 | 03/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788589875 | CMS |
| PBG PUERTO RICO LLC | $20.20 | 06/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832579491 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.